Meridian Bioscience (VIVO) Tops Q4 EPS by 4c, Revenue Beat; Offers FY19 EPS Guidance Below Consensus
Go back to Meridian Bioscience (VIVO) Tops Q4 EPS by 4c, Revenue Beat; Offers FY19 EPS Guidance Below Consensus| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.45 -0.07 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.52 | 52 Week High | $21.49 | |||
| Open | $5.82 | 52 Week Low | $15.75 | |||
| Day High | $5.87 | P/E | 6.19 | |||
| Day Low | $5.14 | EPS | $0.88 | |||
| Volume | 2,271,886 | |||||
